sábado, 8 de agosto de 2009

Influenza Virus Vaccine for the 2009-2010 Season Cumulative 2009/2010 Season Lot Release Status (Updated 8/5/2009)


Influenza Virus Vaccine for the 2009-2010 Season
Cumulative 2009/2010 Season Lot Release Status (Updated 8/5/2009)
Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers. For information on flu vaccine distribution schedules, please contact the manufacturers directly.


Vaccine & Manufacturer Total number of Lots
Released by FDA
AFLURIA
CSL Limited 23
FluLaval
ID Biomedical Corp. of Quebec 3
FluMist
MedImmune, LLC 23
Fluvirin
Novartis Vaccines and Diagnostics Limited 3
Fluzone
Sanofi Pasteur, Inc. 18

FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Silver Spring, Maryland, on February 18, 2009, to select the influenza virus strains for the composition of the influenza vaccine for use in the 2009-2010 U.S. influenza season. During this meeting, the advisory panel reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics, serological responses to 2008/2009 vaccines, and the availability of candidate strains and reagents.

The panel recommended that vaccines to be used in the 2009-2010 influenza season in the U.S. contain the following:

an A/Brisbane/59/2007 (H1N1)-like virus; *
an A/Brisbane/10/2007 (H3N2)-like virus; **
a B/Brisbane/60/2008-like virus.
*A/Brisbane/59/2007 is a current vaccine virus; A/South Dakota/6/2007 (an A/Brisbane/59/2007-like virus) is a current vaccine virus used in live attenuated vaccines.
**A/Brisbane/10/2007 and A/Uruguay/716/2007 (an A/Brisbane/10/2007-like virus) are current vaccine viruses.


The influenza vaccine composition to be used in the 2009-2010 influenza season in the U.S. is identical to that recommended by the World Health Organization on February 12, 2009, for the Northern Hemisphere's 2009-2010 influenza season.


-Approved Influenza Vaccines:
.AFLURIA
..CSL Limited (Afluria)
.Fluarix
...GlaxoSmithKline Biologicals
.FluLaval
....ID Biomedical Corp. of Quebec
.FluMist
.....MedImmune, LLC
.Fluvirin
......Novartis Vaccines and Diagnostics Ltd.
.Fluzone
.......Sanofi Pasteur, Inc.

--Related Information
FDA Approves Vaccine for 2009-2010 Seasonal Influenza
FDA Approves New Influenza Vaccine Production Facility
Get Set for Winter Illness Season
Importance of Influenza Vaccination for Health Care Personnel
- Contact Us(800) 835-4709
(301) 827-1800
ocod@fda.hhs.gov
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

abrir aquí para acceder al documento FDA sobre vacunas de la influenza 2009-2010 (da acceso a información clínico-médica específica):
Influenza Virus Vaccine for the 2009-2010 Season

No hay comentarios:

Publicar un comentario